Company intelligence / Profile preview

SuperGen, Inc.

Dublin, California, USAbristol.ac.uk ↗
Ownership
Private
Employees
~90
Development stage
Other
01

Overview

SuperGen was a US-based oncology pharmaceutical company focused on small molecule therapeutics targeting epigenetic regulation and cell signaling pathways. Its most notable product was Dacogen® for AML/MDS. The company developed proprietary technologies such as CLIMB®, acquired Montigen Pharmaceuticals for additional preclinical assets/platforms in 2006, then merged with UK-based Astex Therapeutics Limited in 2011 to form Astex Pharmaceuticals. The combined entity continued developing a robust oncology pipeline before being acquired by Otsuka Pharmaceutical Co., Ltd., in October 2013.

Therapeutic areas
HematologyOncology
Modalities
Small moleculesMulti-targeted tyrosine kinase inhibitorsDNA methyltransferase inhibitorsOncology-focused drug discovery platforms
Industry
Biotech
02

Drug pipeline

3 assets

Synchotrope TA2M

1

2 more assets in the full pipeline.

Request access →
03

Partnerships

Eisai Co., Ltd.Johnson & JohnsonGlaxoSmithKlineNovartisAstraZeneca

Beyond the preview

Go deeper on SuperGen, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SuperGen, Inc..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call